Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Amgen Invests $3B to Expand Mfg. Facility in North Carolina | Contract Pharma

What are you searching for?

Sign in
Breaking News

Amgen Invests $3B to Expand Mfg. Facility in North Carolina

To establish a second drug substance manufacturing facility in Holly Springs.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Amgen is investing $1 billion to establish a second drug substance manufacturing facility in North Carolina. This brings the company’s total planned investment in Holly Springs to more than $1.5 billion, building on its previously announced $550 million commitment.
 
The $1 billion facility will incorporate cutting-edge technologies. In tandem with the existing facility, these investments will create 370 new jobs in the region.
 
“This expansion underscores our unwavering focus on bringing transformative medicines to patients around the world,” said Robert A. Bradway, chairman and chief executive officer at Amgen. “North Carolina will be an important part of our global manufacturing network as we continue to meet the growing demand for our innovative therapies while generating significant local economic impact.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics